'Study duration' diaporamas de présentation

Updates and Lessons Learned from Pediatric Trials Network (PTN)

310 views • 30 slides

Immunogenicity and safety of the HPV-6, -11, -16, -18 Vaccine in Hiv -positive young women

Immunogenicity and safety of the HPV-6, -11, -16, -18 Vaccine in Hiv -positive young women. J. Kahn, J. Xu, B. Kapogiannis, B. Rudy, N. Liu, R. Gonin, C. Wilson, C. Worrell, K. Squires, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions . AIDS 2012 25 July 2012.

374 views • 26 slides

Introduction to Patient Safety Research

Introduction to Patient Safety Research. Presentation 7 - Understanding Causes: Ethnographic Study. 2: Table of Contents. Introduction Overview Study Details Patient Safety Research Team Background Opening Points Study Rationale Setting Up a Research Team Methods

311 views • 22 slides

Drug-Eluting and Bare Metal Stenting for Acute Myocardial Infarction in Massachusetts

358 views • 22 slides

Clinical Endpoint Bioequivalence Studies for Locally Acting Drugs

Clinical Endpoint Bioequivalence Studies for Locally Acting Drugs. Dena R. Hixon, M.D. Associate Director of Medical Affairs Office of Generic Drugs . Systemic Drugs. Delivered to the bloodstream for distribution to site(s) of action in the body BE determined with PK studies

706 views • 10 slides

2008 ERCOT LaaRs CAPABILITY STUDY

2008 ERCOT LaaRs CAPABILITY STUDY. Conducted by ERCOT DWG. STUDY DURATION. Long study duration. Required engineering people-hours >>> Available engineering people-hours.

153 views • 4 slides